TNDM News

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of Tandem Mobi for use as the worlds first and only tubeless automated insulin delivery system with up to 7 days of wear.1 A new...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of Health Canada approval of a license amendment for the t:slim X2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology. This approval adds...

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +62.96% and +6.94%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (Tandem or the Company), a global diabetes technology company, today announced the appointment of Jeannette Bankes as president and chief executive officer (CEO), and a member of its Board of Directors, effective November 16, 2026. Ms. Bankes will succeed...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Sales of $283.7 million worldwide, including $191.0 million in...

PROCEPT BIOROBO (PRCT) delivered earnings and revenue surprises of -17.95% and -1.78%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:Jefferies Global Healthcare Conference on Thursday, November 19, 2026 at 8:00am Greenwich Mean...

Rapid Micro Biosystems (RPID) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.